Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease

Inclusion Criteria:

1. Male or female patients of any race, 20 years or older who are scheduled forunilateral cataract surgery.
2. DED patients whose symptoms and signs are aggravated at baseline assessment aftercataract surgery will be eligible for this study. Postoperative dry eye diagnosiscriteria at baseline assessment:
3. OSDI score >14.8* (*Eligible subject mandatory required);
4. positive CFS* (*Eligible subject mandatory required);
5. Schirmer's test score ≤10 mm in 5 minutes (min) (without anesthesia);
6. TBUT ≤5 seconds (sec)

Exclusion Criteria:

1. Patients with allergy to any of the study medications, conjunctival allergy orinfectious disease, history of ocular chemical or thermal burn, Stevens-Johnsonsyndrome or ocular pemphigoid, glaucoma or ocular hypertension, eyelid or lacrimaldisease, any ocular operation within 3 months, graft-versus-host disease (GVHD),non-dry-eye ocular inflammation, trauma, or presence of uncontrolled systemic disease.
2. Before enrollment, corneal contact lens wear, history of severe systemic disease, orother conditions in the Investigator's opinion precluded enrollment.
3. Patients will be withdrawn from the study if they experience complications duringsurgery, or post-surgical ocular hypertension, endophthalmitis, or infectiouskeratitis.